MicroGen Biotech
MicroGen Biotech uses Nature's microbes to reduce toxins in crops while increasing crop yields and reducing pollutants in arable soil.
MicroGen Biotech has raised €3.5M across 1 funding round from 1 investor, most recently a Series A round in Jul 2020. Based in Carlow, Ireland; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.5M
€3,470,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-07
latest 2020-07
Funding by year
EUR raised per yearMicroGen Biotech — funding by year — interactive chart.
Data table
| MicroGen Biotech — funding by year | |
|---|---|
| 2020 | €3.5M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-05 | Series A | €3.5M | Fulcrum Global Capital | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData